“Pathways and compounds I was working at could be used to create new medicines. Um, and you know what the Nih wanted was more basic science and so it was very clear. There was a disconnect. Um, so at the end of my fellowship. It was a tough decision but I sort of abruptly decided that I was not going to not going to pursue academic medicine any further. Although I still wanted to treat patients I never wanted to be too far from the bedside.”